Pain intensity after laseruvulopalatoplasty and tonsillectomy

Otolaryngology - Head and Neck Surgery

Volumn 128, Issue 2, 2003, Pages 273-279

  Kokki, Hannu ^a   Nikanne, Elina ^b   Aho, Mikko ^a   Virtaniemi, Jukka ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; FENTANYL CITRATE; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ADOLESCENT; ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DRUG CAPSULE; DRUG USE; FEMALE; HUMAN; LASERUVULOPALATOPLASTY; MAJOR CLINICAL STUDY; MALE; PAIN; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; SCORING SYSTEM; SURGICAL TECHNIQUE; TIME; TONSILLECTOMY;

EID: 0037293390     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhn.2003.82     Document Type: Article

References (16)

1. Colman MF. Risk management in UPPP. Limitation, pitfalls and risk management in palatopharyngoplasty. In: Fairbanks DNF, Fujita S, Ikematsu T, et al, editors. Snoring and obstructive sleep apnoea. New York: Raven Press; 1987. p. 171-84.
2. Dahl JB, Kehlet H. Non-steroidal anti-inflammatory drugs: rationale for use in severe postoperative pain. Br J Anaesth 1991;66:703-12.
3. Vane JR, Botting RM. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 1998;104:2-8.
4. Moren J, Francois T, Blanloeil Y, et al. The effects of a nonsteroidal anti-inflammatory drug (ketoprofen) on morphine respiratory depression: a double-blind, randomized study in volunteers. Anesth Analg 1997;85: 400-5.
5. Niemi TT, Taxell C, Rosenberg PH. Comparison of the effects of intravenous ketoprofen, ketorolac and diclofenac on platelet function in volunteers. Acta Anaesthesiol Scand 1997;41:1353-8.
6. Warnock FF, Lander J. Pain progression, intensity and outcomes following tonsillectomy. Pain 1998;75:37-45.
7. Virtaniemi J, Kokki H, Nikanne E, et al. Ketoprofen and fentanyl for postoperative pain following UPPP and tonsillectomy. Laryngoscope 1999;109:1950-4.
8. World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. 52nd World Medical Association, General Assembly, Edinburgh, Scotland, October 2000.
9. Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2000.
10. Hendolin H, Kansanen M, Koski E, et al. Propofolnitrous oxide versus thiopenthone-isoflurane-nitrous oxide anaesthesia for uvulopharyngoplasty in patients with sleep apnoea. Acta Anaesthesiol Scand 1994;38:694-8.
11. Kostamovaara PA, Hendolin H, Kokki H, et al. Ketorolac, diclofenac and ketoprofen are equally efficacious for pain relief after total hip replacement surgery. Br J Anaesth 1998;81:369-72.
12. Boushra NN. Anaesthetic management of patients with sleep apnoea syndrome. Can J Anaesth 1996;43:599-616.
13. Smith I, Wilde A. Secondary tonsillectomy haemorrhage and non-steroidal anti-inflammatory drugs. J Laryngol Otol 1999;113:28-30.
14. Carenfelt C. Laser uvulopalatoplasty in treatment of habitual snoring. Ann Otol Rhinol Laryngol 1991;100:451-4.
15. Dickson RI, Mintz DI. One-stage laser-assisted uvulopalatoplasty. J Otol 1996;25:155-61.
16. de Meijer A, Vollaard H, de Metz M, et al. Meloxicam, 15 mg/day, spares platelet function in healthy volunteers. Clin Pharmacol Ther 1999;66:425-30.